In India, outdated transfusion technology leaves thousands at risk—while families search desperately for the right blood at the right time.Shweta Chavla Bhattia, PhD and founder of Soul Sense Innovations, saw this crisis up close during her clinical research. Rather than pursue a safe career in academia, she pivoted into entrepreneurship—determined to translate her nanotechnology breakthroughs into scalable, affordable blood diagnostics.
Soul Sense Innovations now leads the way with patented biosensors that deliver rapid, cost-effective blood group screening—recognized by national health institutes and awarded for social impact. Shweta’s story is one of relentless learning, practical invention, and an unwavering commitment to real-world healthcare problems.
Inside this episode:
Why India’s blood banks and hospitals still rely on decades-old screening methods
How Shweta’s patented nano-biosensors cut costs and testing time—without sacrificing accuracy
Lessons in bridging research and business: what it takes to commercialize science in India
The power of partnerships: Collaborating with ICMR NIIH to pilot and scale game-changing technology
Expanding beyond blood typing—tackling blood shelf life, reducing waste, and building a circular health economy
Grit, failure, and growth: what drives Shweta to keep building for impact, not just for headlines
Concrete advice for scientists and first-time founders who want to see their research change lives
Soul Sense Innovations is not just fixing a system, it’s showing how world-class science, executed with empathy and tenacity, can change the future of healthcare.
